Career history of George G Nomikos
Former positions of George G Nomikos
| Companies | Position | Start | End |
|---|---|---|---|
| LIPOCINE INC. | Chief Tech/Sci/R&D Officer | 2022-11-02 | 2023-03-31 |
| SCHOLAR ROCK HOLDING CORPORATION | Chief Tech/Sci/R&D Officer | 2019-09-04 | 2022-11-01 |
| AMGEN INC. | Corporate Officer/Principal | 2007-09-30 | 2007-09-30 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 2005-12-31 | 2005-12-31 |
| Karolinska Institutet | Corporate Officer/Principal | - | - |
| CYNAPSUS THERAPEUTICS INC | Chief Tech/Sci/R&D Officer | 2007-10-29 | - |
Training of George G Nomikos
| National & Kapodistrian University of Athens | Doctorate Degree |
| University of British Columbia | Doctorate Degree |
Statistics
International
| United States | 5 |
| Canada | 3 |
| Greece | 2 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Corporate Officer/Principal | 3 |
| Doctorate Degree | 2 |
Sectoral
| Health Technology | 6 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 4 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| AMGEN INC. | Health Technology |
| ELI LILLY AND COMPANY | Health Technology |
| LIPOCINE INC. | Health Technology |
| Private companies | 1 |
|---|---|
Cynapsus Therapeutics, Inc.
 Cynapsus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Cynapsus Therapeutics, Inc. operated as a pharmaceutical company, which developed an improved dosing formulation of an approved drug used to treat the symptoms of Parkinson's disease. The company was founded by Andrew Williams and David Hill on January 16, 2004 and was headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- George G Nomikos
- Experience
